Summary
The enantiomers of 3-PPP or haloperidol were injected in various doses to rats 1 hour after the established dopamine receptor ligand N,N-dipropyl-5, 6-ADTN. After another 40 minutes the binding of the ligand to the striatum was measured by high performance liquid chromatography, using the level in the cerebellum as “blank”. (−)-3-PPP was found to cause a maximum 71% displacement of the ligand from the striatal binding sites. Haloperidol proved to be more potent but not significantly more efficacious in displacing the ligand. However, the combined treatment with (−)-3-PPP and haloperidol caused a stronger displacement of the ligand than (−)-3-PPP alone, suggesting that the binding-site populations available for the two agents are not fully identical. (+)-3-PPP also caused displacement of the ligand but was considerably less potent than its enantiomeric twin.
The results are discussed against the background of the different pharmacological profiles of the 3-PPP enantiomers and haloperidol. It is suggested that an inverse relationship may exist between receptor affinity and intrinsic activity and that such a relationship may be inherent in the mechanism underlying receptor stimulation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Clark, D., Hjorth, S., Carlsson, A.: Novel dopaminergic agents with selective autoreceptor agonist activity. I. Review of the evidence. J. Neural Transm.62, 1–52 (1985).
Clark, D., Hjorth, S., Carlsson, A.: Novel dopaminergic agents with selective autoreceptor agonist activity. II. Theoretical considerations. J. Neural Transm.62, 171–207 (1985).
Feenstra, M.: Dopamine receptor agonists; neuropharmacological and bioanalytical evaluation. Thesis. Netherlands: University of Groningen. 1984.
Feenstra, M. G. P., Rollema, H., Mulder, T. B. A., Westerink, B. H. C., Horn, A. S.:In vivo dopamine receptor binding studies with a non-radioactively labelled agonist, dipropyl-5,6-ADTN. Life Sci.32, 1313–1323 (1983 a).
Feenstra, M. G. P., Rollema, H., Mulder, T. B. A., De Vries, J. B., Horn, A. S.:In vivo dopamine receptor agonist binding in rat brain: relation with pharmacological effects. Eur. J. Pharmacol.90, 433–436 (1983 b).
Hjorth, S., Carlsson, A., Clark, D., Svensson, K., Sanchez, D.: Dopaminereceptor mediated hypothermia in rats induced by (+)- but not by (−)-3-PPP. Eur. J. Pharmacol.107, 299–304 (1984).
Rollema, H., Mastebroek, D., Wikström, H., Horn, A. S.: In-vitro and in-vivo metabolism of the presynaptic dopamine agonist 3-PPP to a catecholic analogue in rats. J. Pharm. Pharmacol.37, 314–319 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carlsson, A., Löfberg, L. In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum. J. Neural Transmission 64, 173–185 (1985). https://doi.org/10.1007/BF01256465
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01256465